Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
63
STRL Quote, Financials, Valuation and Earnings
Last price:
$250.59
Seasonality move
:
13.42%
Day range:
$244.38 - $253.94
52-week range:
$93.50 - $253.94
Dividend yield:
0%
P/E ratio:
29.29x
P/S ratio:
3.69x
P/B ratio:
9.47x
Volume:
461.3K
Avg. volume:
534.9K
1-year change:
125.24%
Market cap:
$7.6B
Revenue:
$2.1B
EPS (TTM):
$8.56
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.4B | $1.8B | $2B | $2.1B | |
| Revenue Growth (YoY) | 8.92% | 15.3% | 25.1% | 11.46% | 7.28% | |
| Cost of Revenues | $1B | $1.2B | $1.5B | $1.6B | $1.7B | |
| Gross Profit | $179.6M | $203.5M | $274.6M | $337.6M | $426.1M | |
| Gross Profit Margin | 14.64% | 14.39% | 15.52% | 17.12% | 20.14% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $64.3M | $69.2M | $86.5M | $98.7M | $118.4M | |
| Other Inc / (Exp) | -$1.3M | -$2.8M | -$827K | -$873K | $90.9M | |
| Operating Expenses | $86M | $92.6M | $113.9M | $131M | $161.1M | |
| Operating Income | $93.6M | $110.9M | $160.7M | $206.7M | $265M | |
| Net Interest Expenses | $29.2M | $19.3M | $19.7M | $15.2M | -- | |
| EBT. Incl. Unusual Items | $63.1M | $88.8M | $140.2M | $190.6M | $358.3M | |
| Earnings of Discontinued Ops. | -$817K | $1.2M | $9.7M | -- | -- | |
| Income Tax Expense | $19.4M | $24.9M | $41.7M | $47.8M | $87.4M | |
| Net Income to Company | $42.9M | $65.1M | $108.2M | $142.8M | $270.9M | |
| Minority Interest in Earnings | -$598K | -$2.5M | -$1.7M | -$4.2M | -$13.5M | |
| Net Income to Common Excl Extra Items | $42.3M | $62.6M | $106.5M | $138.7M | $257.5M | |
| Basic EPS (Cont. Ops) | $1.52 | $2.19 | $3.20 | $4.51 | $8.35 | |
| Diluted EPS (Cont. Ops) | $1.50 | $2.15 | $3.16 | $4.44 | $8.27 | |
| Weighted Average Basic Share | $27.9M | $28.6M | $30.2M | $30.8M | $30.8M | |
| Weighted Average Diluted Share | $28.2M | $29.1M | $30.6M | $31.2M | $31.1M | |
| EBITDA | $125.2M | $142.3M | $212.8M | $277.3M | $451.9M | |
| EBIT | $92.5M | $108.1M | $160.8M | $219.9M | $383.5M | |
| Revenue (Reported) | $1.2B | $1.4B | $1.8B | $2B | $2.1B | |
| Operating Income (Reported) | $93.6M | $110.9M | $160.7M | $206.7M | $265M | |
| Operating Income (Adjusted) | $92.5M | $108.1M | $160.8M | $219.9M | $383.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $315.3M | $366M | $403.6M | $440.4M | $430.9M | |
| Revenue Growth (YoY) | 6.28% | 16.06% | 10.28% | 9.11% | -2.14% | |
| Cost of Revenues | $270.3M | $310.8M | $341.8M | $363.5M | $336.1M | |
| Gross Profit | $45M | $55.1M | $61.7M | $76.9M | $94.8M | |
| Gross Profit Margin | 14.28% | 15.07% | 15.3% | 17.46% | 22.01% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $17.1M | $20.3M | $23.3M | $27.3M | $34.6M | |
| Other Inc / (Exp) | -$337K | -$255K | -$190K | -$1M | -$1.5M | |
| Operating Expenses | $22.3M | $25.5M | $28.9M | $33.7M | $37.2M | |
| Operating Income | $22.8M | $29.6M | $32.8M | $43.2M | $57.6M | |
| Net Interest Expenses | $6M | $4.6M | $5.6M | $762K | -- | |
| EBT. Incl. Unusual Items | $16.4M | $24.7M | $27.1M | $41.4M | $57.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.8M | $6.8M | $7M | $7.6M | $15.1M | |
| Net Income to Company | $11.7M | $19.5M | $20M | $33.8M | $42.6M | |
| Minority Interest in Earnings | -$1.1M | -$271K | -$391K | -$2.7M | -$3.1M | |
| Net Income to Common Excl Extra Items | $10.6M | $17.7M | $19.6M | $31M | $39.5M | |
| Basic EPS (Cont. Ops) | $0.37 | $0.64 | $0.64 | $1.00 | $1.29 | |
| Diluted EPS (Cont. Ops) | $0.37 | $0.64 | $0.64 | $1.00 | $1.28 | |
| Weighted Average Basic Share | $28.3M | $30M | $30.6M | $31M | $30.5M | |
| Weighted Average Diluted Share | $28.8M | $30.1M | $30.8M | $31.2M | $30.9M | |
| EBITDA | $30.7M | $41.1M | $48.3M | $64.3M | $79.9M | |
| EBIT | $22.4M | $29.4M | $34.6M | $48M | $62.9M | |
| Revenue (Reported) | $315.3M | $366M | $403.6M | $440.4M | $430.9M | |
| Operating Income (Reported) | $22.8M | $29.6M | $32.8M | $43.2M | $57.6M | |
| Operating Income (Adjusted) | $22.4M | $29.4M | $34.6M | $48M | $62.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.5B | $1.8B | $2B | $2.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.1B | $1.3B | $1.5B | $1.7B | $1.7B | |
| Gross Profit | $189.4M | $213.6M | $281.2M | $352.8M | $444.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $63.8M | $72.4M | $89.5M | $102.7M | $125.8M | |
| Other Inc / (Exp) | -$1.2M | -$2.7M | -$762K | -$1.7M | $89.4M | |
| Operating Expenses | $85.6M | $95.9M | $117.3M | $135.8M | $163.6M | |
| Operating Income | $103.8M | $117.8M | $163.9M | $217M | $280.5M | |
| Net Interest Expenses | $27.5M | $17.9M | $20.6M | $10.4M | -- | |
| EBT. Incl. Unusual Items | $75.2M | $97.1M | $142.5M | $204.9M | $374.6M | |
| Earnings of Discontinued Ops. | -- | -- | $8.2M | -- | -- | |
| Income Tax Expense | $23M | $26.9M | $42M | $48.3M | $94.8M | |
| Net Income to Company | $51.4M | $73M | $108.7M | $156.6M | $279.8M | |
| Minority Interest in Earnings | -$1.6M | -$1.6M | -$1.9M | -$6.5M | -$13.9M | |
| Net Income to Common Excl Extra Items | $49.7M | $69.8M | $106.9M | $150.1M | $265.9M | |
| Basic EPS (Cont. Ops) | $1.77 | $2.46 | $3.53 | $4.86 | $8.66 | |
| Diluted EPS (Cont. Ops) | $1.76 | $2.42 | $3.50 | $4.81 | $8.56 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $135.5M | $152.7M | $220M | $293.3M | $467.6M | |
| EBIT | $102.7M | $115.1M | $166M | $233.4M | $398.4M | |
| Revenue (Reported) | $1.2B | $1.5B | $1.8B | $2B | $2.1B | |
| Operating Income (Reported) | $103.8M | $117.8M | $163.9M | $217M | $280.5M | |
| Operating Income (Adjusted) | $102.7M | $115.1M | $166M | $233.4M | $398.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $315.3M | $366M | $403.6M | $440.4M | $430.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $270.3M | $310.8M | $341.8M | $363.5M | $336.1M | |
| Gross Profit | $45M | $55.1M | $61.7M | $76.9M | $94.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $17.1M | $20.3M | $23.3M | $27.3M | $34.6M | |
| Other Inc / (Exp) | -$337K | -$255K | -$190K | -$1M | -$1.5M | |
| Operating Expenses | $22.3M | $25.5M | $28.9M | $33.7M | $37.2M | |
| Operating Income | $22.8M | $29.6M | $32.8M | $43.2M | $57.6M | |
| Net Interest Expenses | $6M | $4.6M | $5.6M | $762K | -- | |
| EBT. Incl. Unusual Items | $16.4M | $24.7M | $27.1M | $41.4M | $57.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.8M | $6.8M | $7M | $7.6M | $15.1M | |
| Net Income to Company | $11.7M | $19.5M | $20M | $33.8M | $42.6M | |
| Minority Interest in Earnings | -$1.1M | -$271K | -$391K | -$2.7M | -$3.1M | |
| Net Income to Common Excl Extra Items | $10.6M | $17.7M | $19.6M | $31M | $39.5M | |
| Basic EPS (Cont. Ops) | $0.37 | $0.64 | $0.64 | $1.00 | $1.29 | |
| Diluted EPS (Cont. Ops) | $0.37 | $0.64 | $0.64 | $1.00 | $1.28 | |
| Weighted Average Basic Share | $28.3M | $30M | $30.6M | $31M | $30.5M | |
| Weighted Average Diluted Share | $28.8M | $30.1M | $30.8M | $31.2M | $30.9M | |
| EBITDA | $30.7M | $41.1M | $48.3M | $64.3M | $79.9M | |
| EBIT | $22.4M | $29.4M | $34.6M | $48M | $62.9M | |
| Revenue (Reported) | $315.3M | $366M | $403.6M | $440.4M | $430.9M | |
| Operating Income (Reported) | $22.8M | $29.6M | $32.8M | $43.2M | $57.6M | |
| Operating Income (Adjusted) | $22.4M | $29.4M | $34.6M | $48M | $62.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $66.2M | $60.9M | $181.5M | $471.6M | $664.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $177.4M | $200.2M | $262.6M | $252.4M | $247.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $16.3M | $16M | $29.1M | $17.9M | $17.4M | |
| Total Current Assets | $361.5M | $434.7M | $597.3M | $848M | $1B | |
| Property Plant And Equipment | $143.2M | $213.4M | $274.9M | $300.9M | $289.5M | |
| Long-Term Investments | -- | -- | -- | -- | $107.4M | |
| Goodwill | $192M | $258.3M | $262.7M | $281.1M | $264.6M | |
| Other Intangibles | $244.9M | $303.2M | $299.1M | $328.4M | $316.4M | |
| Other Long-Term Assets | $11.1M | $25.2M | $7.7M | $18.8M | $17M | |
| Total Assets | $952.7M | $1.2B | $1.4B | $1.8B | $2B | |
| Accounts Payable | $95.2M | $112.7M | $121.9M | $146M | $130.4M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $77.4M | $23.4M | $32.6M | $26.5M | $26.4M | |
| Current Portion Of Capital Lease Obligations | $7.6M | $6.6M | $19.7M | $19.6M | $20.5M | |
| Other Current Liabilities | $9.6M | $70M | $9M | $14.1M | $19M | |
| Total Current Liabilities | $321.9M | $351.8M | $446.6M | $678.2M | $742M | |
| Long-Term Debt | $291.2M | $428.5M | $398.7M | $315M | $289.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $684M | $874.5M | $963.8M | $1.2B | $1.2B | |
| Common Stock | $283K | $298K | $306K | $309K | $312K | |
| Other Common Equity Adj | -$5.3M | -$1.7M | -- | -- | -- | |
| Common Equity | $267.3M | $358.8M | $474.6M | $618.9M | $808.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.5M | $1.5M | $3.2M | $4.9M | $18.4M | |
| Total Equity | $268.7M | $360.2M | $477.8M | $623.9M | $826.5M | |
| Total Liabilities and Equity | $952.7M | $1.2B | $1.4B | $1.8B | $2B | |
| Cash and Short Terms | $66.2M | $60.9M | $181.5M | $471.6M | $664.2M | |
| Total Debt | $368.7M | $451.9M | $431.3M | $341.5M | $316.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $61.4M | $80.4M | $202.6M | $480.4M | $638.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $170.2M | $226.4M | $230.1M | $274M | $285.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $15.4M | $21.9M | $13M | $17.9M | $17.7M | |
| Total Current Assets | $355.2M | $435.9M | $588M | $878.9M | $997.7M | |
| Property Plant And Equipment | $151.2M | $249.9M | $277.5M | $314M | $292.9M | |
| Long-Term Investments | -- | -- | -- | -- | $109.3M | |
| Goodwill | $192M | $252.4M | $262.7M | $281.4M | $283.7M | |
| Other Intangibles | $242M | $300.1M | $295.4M | $324.1M | $333.7M | |
| Other Long-Term Assets | $3.3M | $4.5M | $7.6M | $19.2M | $17.2M | |
| Total Assets | $947.2M | $1.2B | $1.4B | $1.8B | $2B | |
| Accounts Payable | $111.1M | $143.4M | $119.5M | $135.4M | $128.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $60M | $30.4M | $35.1M | $26.5M | $26.4M | |
| Current Portion Of Capital Lease Obligations | $7.6M | $10.1M | $17.4M | $19.1M | $19.3M | |
| Other Current Liabilities | $9.9M | $13.6M | $13.6M | $19.8M | $22.8M | |
| Total Current Liabilities | $322.2M | $339.5M | $444.7M | $705.7M | $756.8M | |
| Long-Term Debt | $279.2M | $417.3M | $365.5M | $308.7M | $283.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $671.5M | $865.1M | $932.9M | $1.2B | $1.2B | |
| Common Stock | $286K | $302K | $308K | $311K | $312K | |
| Other Common Equity Adj | -$4.4M | -$160K | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $613K | $1.7M | $3.6M | $7.7M | $21.5M | |
| Total Equity | $275.7M | $377.6M | $498.3M | $652.2M | $826.9M | |
| Total Liabilities and Equity | $947.2M | $1.2B | $1.4B | $1.8B | $2B | |
| Cash and Short Terms | $61.4M | $80.4M | $202.6M | $480.4M | $638.6M | |
| Total Debt | $339.1M | $447.7M | $400.6M | $335.2M | $310M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $42.9M | $65.1M | $108.2M | $142.8M | $270.9M | |
| Depreciation & Amoritzation | $32.8M | $34.2M | $52.1M | $57.4M | $68.4M | |
| Stock-Based Compensation | $11.6M | $11.8M | $12.7M | $14.6M | $19M | |
| Change in Accounts Receivable | $50M | $4.4M | $9.4M | $235.5M | $194.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $122.9M | $158.9M | $219.1M | $478.6M | $497.1M | |
| Capital Expenditures | $32.9M | $46.7M | $60.9M | $64.4M | $81M | |
| Cash Acquisitions | -- | -$180.9M | -$33.8M | -$37.2M | -$115.1M | |
| Cash From Investing | -$30.5M | -$223.4M | -$89.8M | -$87.8M | -$185.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $140M | -- | $2.6M | -- | |
| Long-Term Debt Repaid | -$77.7M | -$48.3M | -$23.4M | -$93.5M | -$26.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$70.6M | |
| Other Financing Activities | $7.4M | -$11.2M | -$9.4M | -$13.6M | -$21.5M | |
| Cash From Financing | -$70.3M | $80.6M | -$32.8M | -$104.5M | -$118.6M | |
| Beginning Cash (CF) | $50.6M | $72.6M | $88.7M | $185.3M | $471.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $22.1M | $16.1M | $96.6M | $286.3M | $192.6M | |
| Ending Cash (CF) | $72.6M | $88.7M | $185.3M | $471.6M | $664.2M | |
| Levered Free Cash Flow | $90M | $112.3M | $158.2M | $414.2M | $416.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $11.7M | $19.5M | $20M | $33.8M | $42.6M | |
| Depreciation & Amoritzation | $8.3M | $11.8M | $13.7M | $16.3M | $17M | |
| Stock-Based Compensation | $1.8M | $2.6M | $3.2M | $4.6M | $6.7M | |
| Change in Accounts Receivable | -$2.2M | -$13M | $20.3M | $18.9M | $30.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $38.1M | $26.6M | $49.1M | $49.6M | $84.9M | |
| Capital Expenditures | $11.2M | $15M | $14.2M | $22.4M | $17.9M | |
| Cash Acquisitions | -- | -- | $14M | -$1M | -$37.9M | |
| Cash From Investing | -$11M | -$14.6M | $6.5M | -$21M | -$54.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$30.5M | -$5.9M | -$30.8M | -$6.7M | -$6.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$43.8M | |
| Other Financing Activities | -$2M | -$7.4M | -$4.3M | -$13M | -$5.8M | |
| Cash From Financing | -$32.5M | -$13.3M | -$35.1M | -$19.7M | -$56.2M | |
| Beginning Cash (CF) | $72.6M | $88.7M | $185.3M | $471.6M | $664.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$5.4M | -$1.3M | $20.4M | $8.9M | -$25.5M | |
| Ending Cash (CF) | $61.4M | $87.4M | $202.6M | $480.4M | $638.6M | |
| Levered Free Cash Flow | $26.9M | $11.6M | $34.8M | $27.2M | $67M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $51.4M | $73M | $108.7M | $156.6M | $279.8M | |
| Depreciation & Amoritzation | $32.8M | $37.7M | $54M | $60M | $69.1M | |
| Stock-Based Compensation | $11.2M | $12.5M | $13.4M | $16M | $21.1M | |
| Change in Accounts Receivable | $40.3M | -$6.4M | $42.7M | $234M | $206.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $150.2M | $147.4M | $241.6M | $479.1M | $532.4M | |
| Capital Expenditures | $36.7M | $50.4M | $60.2M | $72.6M | $76.4M | |
| Cash Acquisitions | -- | -$180.9M | -$19.8M | -$52.2M | -$151.9M | |
| Cash From Investing | -$34.7M | -$227M | -$68.7M | -$115.3M | -$219M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$103.2M | -$23.7M | -$48.3M | -$69.3M | -$26.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$114.4M | |
| Other Financing Activities | $6.1M | -$16.6M | -$6.3M | -$22.3M | -$14.2M | |
| Cash From Financing | -$127.1M | $99.8M | -$54.6M | -$89.1M | -$155.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$11.5M | $20.2M | $118.3M | $274.7M | $158.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $113.5M | $97M | $181.4M | $406.5M | $456M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $11.7M | $19.5M | $20M | $33.8M | $42.6M | |
| Depreciation & Amoritzation | $8.3M | $11.8M | $13.7M | $16.3M | $17M | |
| Stock-Based Compensation | $1.8M | $2.6M | $3.2M | $4.6M | $6.7M | |
| Change in Accounts Receivable | -$2.2M | -$13M | $20.3M | $18.9M | $30.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $38.1M | $26.6M | $49.1M | $49.6M | $84.9M | |
| Capital Expenditures | $11.2M | $15M | $14.2M | $22.4M | $17.9M | |
| Cash Acquisitions | -- | -- | $14M | -$1M | -$37.9M | |
| Cash From Investing | -$11M | -$14.6M | $6.5M | -$21M | -$54.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$30.5M | -$5.9M | -$30.8M | -$6.7M | -$6.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$43.8M | |
| Other Financing Activities | -$2M | -$7.4M | -$4.3M | -$13M | -$5.8M | |
| Cash From Financing | -$32.5M | -$13.3M | -$35.1M | -$19.7M | -$56.2M | |
| Beginning Cash (CF) | $72.6M | $88.7M | $185.3M | $471.6M | $664.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$5.4M | -$1.3M | $20.4M | $8.9M | -$25.5M | |
| Ending Cash (CF) | $61.4M | $87.4M | $202.6M | $480.4M | $638.6M | |
| Levered Free Cash Flow | $26.9M | $11.6M | $34.8M | $27.2M | $67M | |
Get STRL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
STRL
Sector
P/E ratio
29.29x
18.58x
PEG ratio
0.38x
0.25x
P/B ratio
9.47x
1.75x
Price / LTM sales
3.69x
0.94x
Growth Metrics
STRL
Sector
Revenue growth
-2.14%
1.98%
Earnings growth
28%
2.46%
Revenue (5-year growth)
13.44%
4.35%
Earnings forecast
$2.25
$0.40
Profitability
STRL
Sector
Profitability FY 2024
$426.1M
$393.9M
Return on invested capital
24.94%
5.32%
Return on assets
13.49%
3.49%
Return on equity
35.76%
8.55%
Earnings Date
Last Earnings Date
May
5
Next Earnings Date
Aug
5
Estimated Next Earnings Date
Aug
4
Balance Sheet
STRL
Sector
Total cash
$638.6M
$154.3M
Short term investments
--
$35.5M
Total assets
$2B
$1.7B
Long term debt
$310M
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
